Skip to main content
logo
Wave Life Sciences Ltd. (WVE)
NASDAQ: WVE · Real-Time Price · USD
6.58
+0.11 (1.70%)
At close: May 29, 2026, 4:00 PM EDT
6.62
+0.04 (0.61%)
After-hours: May 29, 2026, 7:18 PM EDT

Wave Life Sciences Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
71.842.73108.3113.313.6540.96
Revenue Growth (YoY)
-31.58%-60.55%-4.42%3005.10%-91.09%104.03%
Gross Profit
71.842.73108.3113.313.6540.96
Selling, General & Admin
79.0875.3359.0251.2950.5146.11
Research & Development
189.6182.78159.68130.01115.86121.88
Total Operating Expenses
268.68258.11218.71181.3166.37167.98
Operating Income
-56.47-215.38-110.4-68-162.72-127.02
Interest Income
12.8910.4810.167.931.570.03
Other Non-Operating Income (Expense)
0.40.533.231.880.014.54
Total Non-Operating Income (Expense)
13.2911.0113.49.811.584.57
Pretax Income
-53.18-204.38-97.01-58.19-161.14-122.45
Net Income
-53.18-204.38-97.01-57.51-161.82-122.25
Net Income to Common
-53.18-204.38-97.01-57.51-161.82-122.25
Shares Outstanding (Basic)
1781691381067952
Shares Outstanding (Diluted)
1781691381067952
Shares Change (YoY)
19.28%21.96%30.33%34.55%52.16%32.12%
EPS (Basic)
-1.06-1.21-0.70-0.54-2.05-2.36
EPS (Diluted)
-1.06-1.21-0.70-0.54-2.05-2.36
Shares Outstanding
192.34187.66153.04109.6386.9259.84
Free Cash Flow
-185-188.21-151.96-20.55-129.14-89.55
Free Cash Flow Per Share
-1.04-1.12-1.10-0.19-1.64-1.73
Gross Margin
100.00%100.00%100.00%100.00%100.00%100.00%
Operating Margin
-78.65%-504.09%-101.94%-60.01%-4459.30%-310.07%
Profit Margin
-74.07%-478.34%-89.57%-50.76%-4434.72%-298.42%
FCF Margin
-257.66%-440.50%-140.31%-18.13%-3539.11%-218.61%
EBITDA
-53.06-211.94-106.51-63-156.15-119.53
EBITDA Margin
-73.90%-496.04%-98.34%-55.60%-4279.14%-291.80%
EBIT
-56.47-215.38-110.4-68-162.72-127.02
EBIT Margin
-78.65%-504.09%-101.94%-60.01%-4459.30%-310.07%
SEC Filings: 10-K · 10-Q